Market Tracker

02/21 5:15pm ET

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

3.30
Delayed Data
As of 3:57pm ET
 -0.18 / -5.17%
Today’s Change
2.91
Today|||52-Week Range
11.20
-40.63%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close3.48
Today’s open3.46
Day’s range3.26 - 3.58
Volume80,006
Average volume (3 months)55,683
Market cap$7.6M
Data as of 3:57pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)+21.90%
Earnings growth (this year)+44.46%
Earnings growth (next 5 years)--
Revenue growth (last year)-44.12%
P/E ratioNM
Price/Sales253.76
Price/Book0.57

Competitors

 Today’s
change
Today’s
% change
XTNTXtant Medical Holdin...-1.19-16.30%
NDRAENDRA Life Sciences ...-0.10-3.02%
SNGXSoligenix Inc+0.03+1.30%
CURNeuralstem Inc-0.14-8.24%
Data as of 4:00pm ET, 02/21/2018

Financials

Next reporting dateMarch 29, 2018
EPS forecast (this quarter)-$1.70
Annual revenue (last year)$19.0K
Annual profit (last year)-$9.0M
Net profit margin-47,336.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts